Publicador de contenidos

Investigación e Innovación Programas
Investigación, Salud Materna, Infantil y Reproductiva

Preparando la implementación de nuevas vacunas en el embarazo: Estudio de las barreras y facilitadores de la aceptabilidad de vacunas en embarazadas

Project Code: PI19/01346

Duración
01/01/2020 - 31/12/2022
Coordinador
Azucena Bardají
Financiadores
Instituto de Salud Carlos III Unión Europea Este proyecto está cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER). “Una manera de hacer Europa”

Maternal immunization is an excellent evidence-based approach for preventing severe disease and decreasing neonatal and infant deaths. Tetanus, pertussis and influenza vaccines are recommended for pregnant women globally, however, despite the proven benefits and availability of safe and effective vaccines, as well as the recommendations by the World Health Organization, coverage among pregnant women remains sub-optimal.

New maternal vaccines against respiratory syncytial virus (RSV) and Group B Streptococcus (GBS) will be available in the upcoming years. Understanding baseline awareness and perceived risk and benefits of maternal immunization among pregnant women and health care providers is essential to better anticipate acceptance of new maternal immunization strategies.

This study aims to advance in the understanding of potential barriers and facilitators to maternal vaccine acceptance in preparation for wide implementation and uptake of future vaccines in pregnancy. In order to address this, we propose to conduct a mixed-methods research study on the drivers that influence maternal vaccine acceptance among pregnant women and health care providers.

This study is expected to provide the information needed to guide decisions and approaches for effective implementation of future maternal vaccines.

 

Financiación:

52.000 €

 

 

Nuestro equipo

Coordinator

Otros proyectos

Ver proyectos pasados

CaDMIA-plus

Validación continuada de la autopsia mínimamente invasiva (MIA) para la investigación de la causa de muerte en niños pequeños, y desarrollo de un centro de investigación y formación sobre el estudio de la causa de muerte

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

MIBio

Identification of Prematurity and Pre-Eclampsia as Causes of Mortality

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

MA-CoV

Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations

IPERVAC-SL

Impact of perceptions of COVID-19 vaccines on health-seeking behaviours in Sierra Leone

RESPIRE

Respiratory syncytial virus (RSV) in African pregnant women and children

VITAL

Towards preparedness for new maternal vaccinations: Understanding barriers and facilitators to maternal vaccine acceptance

HIV drug resistance (HIVDR)

Description of HIV drug resistance patterns and its association with the risk of HIV mother to child transmission among pregnant women from southern Mozambique